Dynveo — Ubiquinol Kaneka™ 100mg 60 capsules

Ubiquinol is the reduced (unoxidized) form of CoQ10, which accounts for about 90% of the circulating CoQ10 in the blood of a healthy individual. Unlike ubiquinone (the oxidized form), ubiquinol does not need to be converted by the body before use, which explains its superior bioavailability, as measured in several published studies. Endogenous CoQ10 synthesis declines with age, statin treatments, and certain oxidative stress conditions. The choice of Kaneka™ form is clinically justified: it is the most widely used reference in published ubiquinol studies, derived from a bio-fermentation process without chemical synthesis, and its purity is tested by HPLC. Flash™ Microencapsulation solves the historical problem of ubiquinol's instability to oxidation. The absence of polysorbate (E433), an excipient used in conventional softgels, is a relevant formulation point. The formula contains no declared chemical additives or excipients — only acacia fiber, dextrin, vitamin C (encapsulation matrix), and pullulan (vegetable capsule) are listed in the ingredients. Main warning: documented interaction between CoQ10 and oral anticoagulants (warfarin, acenocoumarol). CoQ10 can reduce the anticoagulant effect (antagonism on vitamin K-dependent coagulation factors). Any patient taking anticoagulants must consult their doctor before use. Furthermore, statins reduce endogenous CoQ10 synthesis — ubiquinol is often recommended in parallel, but this requires medical supervision. Current European legislation (EC Regulation 1924/2006) does not provide authorized health claims for CoQ10. The information shared in this document describes the molecule and its biology, based on scientific publications, not health claims. Manufacturer data · studies on the Kaneka™ Ubiquinol form.